MetaCap

NuCana plc ADR (NCNA)

NASDAQ: NCNAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.7495+0.0315 (+4.39%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

NCNA stock chart

Technical analysis

Key statistics

All statistics
52-week range
0.62 – 4.55
Day range
0.7026 – 0.7899
Volume / Avg
25.52K / 118.13K
Beta
—

52-week range

$0.62$4.55

NCNA stock today

NuCana (NCNA) closed at $0.7495 on Nov 20, up 4.39% (+$0.0315), versus the S&P 500's 3.70% decline. Trading was light, with 25.52K shares changing hands, about 22% of the average daily volume. At this level, NCNA sits near the bottom of its 52-week range of $0.62 to $4.55: 83.5% below the high and 20.9% above the low.

NuCana has posted a net loss over the last twelve months (EPS of $0.00), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About NuCana

Company profile

NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer in the United States. It applies its ProTide technology to transform prescribed chemotherapy agents and nucleoside analogs into medicines. The company is developing medicines to overcome the limitations of nucleoside analogs and generate concentrations of anti-cancer metabolites in cancer cells.

Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Hugh Stephen Griffith
Headquarters
Edinburgh
Employees
10
IPO year
2017
Website
nucana.com

Earnings

Earnings history
Last reported (Sep/2026)
Nov 12, 2026
EPS actual vs est.
$-0.10 vs —

NCNA news

All NCNA news

NuCana peers

Health Care sector
NCNA peer companies
CompanyPrice% ChgMarket capCompare
BGMSBio Green Med Solution Inc.0.553-9.48%$3.66Mvs NCNA
SILOSilo Pharma Inc.1.71-9.04%$3.69Mvs NCNA
ALZNAlzamend Neuro Inc.0.7758-23.94%$3.74Mvs NCNA
IMNNImunon Inc.0.5355-5.22%$3.47Mvs NCNA
XTLBXTL Biopharmaceuticals Ltd. ADR1.37-5.84%$3.37Mvs NCNA
LTRNLantern Pharma Inc.0.245-13.73%$3.89Mvs NCNA
XBIOXenetic Biosciences Inc.1.40-9.09%$3.28Mvs NCNA
APREAprea Therapeutics Inc.0.229-53.56%$3.25Mvs NCNA

Indexes, lists and sector

NuCana stock FAQ

What is NuCana's stock price today?

NCNA last traded at $0.7495 as of Nov 20, 4:00 PM EST, up 4.39% on the day. Prices are delayed at least 15 minutes.

Who is NuCana's CEO?

Mr. Hugh Stephen Griffith is the chief executive officer of NuCana plc ADR, which has about 10 employees.

What is the NCNA 52-week high?

The 52-week high for NCNA is $4.55 and the 52-week low is $0.62. The stock is currently 83.5% below its high.

Compare NCNA